208 related articles for article (PubMed ID: 28508984)
1. Successful treatment of myeloma cast nephropathy using bortezomib-based chemotherapy plus selective plasma exchange.
Kawabe M; Yamamoto I; Katsuma A; Hayashi N; Komatsuzaki Y; Nakada Y; Shimizu A; Tanno Y; Ohkido I; Tsuboi N; Suzuki K; Shimada T; Ogasawara Y; Sugiyama K; Aiba K; Yokoo T
CEN Case Rep; 2016 Nov; 5(2):232-237. PubMed ID: 28508984
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of blood purification and bortezomib plus dexamethasone therapy for the treatment of acute renal failure due to myeloma cast nephropathy.
Hasegawa M; Kondo F; Yamamoto K; Murakami K; Tomita M; Nabeshima K; Nakai S; Kato M; Ohashi A; Arai J; Hiki Y; Ishii J; Emi N; Sugiyama S; Yuzawa Y
Ther Apher Dial; 2010 Oct; 14(5):451-6. PubMed ID: 21175542
[TBL] [Abstract][Full Text] [Related]
3. Rapid reduction of extremely high kappa free light chains in a patient with myeloma cast nephropathy.
Snozek CLH; Kinard TN; Adamski J
J Clin Apher; 2018 Jun; 33(3):439-443. PubMed ID: 29427353
[TBL] [Abstract][Full Text] [Related]
4. Combined proximal tubulopathy, crystal-storing histiocytosis, and cast nephropathy in a patient with light chain multiple myeloma.
Wu CK; Yang AH; Lai HC; Lin BS
BMC Nephrol; 2017 May; 18(1):170. PubMed ID: 28545410
[TBL] [Abstract][Full Text] [Related]
5. Successful renal recovery from multiple myeloma-associated crystalline light chain cast nephropathy and accompanying acute kidney injury with early use of bortezomib-based therapy: a case report and literature review.
Miki K; Shimamura Y; Maeda T; Moniwa N; Ogawa Y; Shimizu T; Hayashi T; Sakai H; Takizawa H
CEN Case Rep; 2023 Feb; 12(1):56-62. PubMed ID: 35854043
[TBL] [Abstract][Full Text] [Related]
6. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
[TBL] [Abstract][Full Text] [Related]
7. Myeloma cast nephropathy: a rare cause of primary renal allograft dysfunction.
Goel SK; Granger D; Bellovich K; Marin M; Qu H; El-Ghoroury M
Transplant Proc; 2011 Sep; 43(7):2784-8. PubMed ID: 21911163
[TBL] [Abstract][Full Text] [Related]
8. Current Trends of Renal Impairment in Multiple Myeloma.
Yadav P; Cook M; Cockwell P
Kidney Dis (Basel); 2016 Mar; 1(4):241-57. PubMed ID: 27536684
[TBL] [Abstract][Full Text] [Related]
9. Management options for cast nephropathy in multiple myeloma.
Cockwell P; Hutchison CA
Curr Opin Nephrol Hypertens; 2010 Nov; 19(6):550-5. PubMed ID: 20827195
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of IHD with Adsorptive PMMA Membrane in Myeloma Cast Nephropathy: A Cohort Study.
Sens F; Chaintreuil D; Jolivot A; Guebre-Egziabher F; Robinson P; Karlin L; Bridoux F; Juillard L
Am J Nephrol; 2017; 46(5):355-363. PubMed ID: 29017155
[TBL] [Abstract][Full Text] [Related]
11. Plasma exchange combined with bortezomib-based chemotherapy is effective for early renal recovery in a patient with IgD-λ type multiple myeloma.
Ueda H; Kuno H; Takahashi D; Katsuma A; Kimura A; Nakashima A; Kato J; Momoki M; Ohba R; Dobashi N; Yamamoto I; Kawamura T; Miyazaki Y; Yokoo T
CEN Case Rep; 2020 May; 9(2):165-172. PubMed ID: 31974826
[TBL] [Abstract][Full Text] [Related]
12. Lambda light chain myeloma with oliguric cast nephropathy and remission with bortezomib, doxorubicin and dexamethasone.
Hada R; Poudyal B; Sharma A; Khatri R
JNMA J Nepal Med Assoc; 2012; 52(188):192-5. PubMed ID: 23591252
[TBL] [Abstract][Full Text] [Related]
13. Treatment by long haemodialysis sessions with high cut-off filters in myeloma cast nephropathy: our experience.
Borrego-Hinojosa J; Pérez-del Barrio MP; Biechy-Baldan Mdel M; Merino-García E; Sánchez-Perales MC; García-Cortés MJ; Ocaña-Pérez E; Gutiérrez-Rivas P; Liébana-Cañada A
Nefrologia; 2013; 33(4):515-23. PubMed ID: 23897183
[TBL] [Abstract][Full Text] [Related]
14. Combination of bortezomib-based chemotherapy and extracorporeal free light chain removal for treating cast nephropathy in multiple myeloma.
Bachmann U; Schindler R; Storr M; Kahl A; Joerres A; Sturm I
NDT Plus; 2008 Apr; 1(2):106-108. PubMed ID: 28657037
[TBL] [Abstract][Full Text] [Related]
15. Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains.
Leung N; Gertz MA; Zeldenrust SR; Rajkumar SV; Dispenzieri A; Fervenza FC; Kumar S; Lacy MQ; Lust JA; Greipp PR; Witzig TE; Hayman SR; Russell SJ; Kyle RA; Winters JL
Kidney Int; 2008 Jun; 73(11):1282-8. PubMed ID: 18385667
[TBL] [Abstract][Full Text] [Related]
16. Extracorporeal treatment of cast nephropathy.
Gakhar B; Kobrin S; Berns JS
Semin Dial; 2011; 24(1):9-11. PubMed ID: 21324000
[TBL] [Abstract][Full Text] [Related]
17. Crystalline Light Chain Casts and Hypercalcemia Induced Acute Kidney Injury: A Rare Presentation of Multiple Myeloma.
Nishigaito T; Mitsumoto K; Katsunuma R; Hirai Y; Yamashita C; Mizumoto A; Uzu T
Intern Med; 2024 Jun; 63(12):1751-1755. PubMed ID: 37926541
[TBL] [Abstract][Full Text] [Related]
18. A case of primary renal allograft dysfunction due to myeloma cast nephropathy.
Lingaraj U; Vankalakunti M; Radhakrishnan H; Sreedhara CG; Rajanna S
Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):970-5. PubMed ID: 26354571
[TBL] [Abstract][Full Text] [Related]
19. Impact of free light chain hemodialysis in myeloma cast nephropathy: a case-control study.
Peters NO; Laurain E; Cridlig J; Hulin C; Cao-Huu T; Frimat L
Hemodial Int; 2011 Oct; 15(4):538-45. PubMed ID: 22111823
[TBL] [Abstract][Full Text] [Related]
20. Sequential, Autologous Hematopoietic Stem Cell Transplant Followed by Renal Transplant in Multiple Myeloma.
Bhowmik D; Yadav S; Kumar L; Agarwal S; Agarwal SK; Gupta S
Indian J Nephrol; 2017; 27(4):324-326. PubMed ID: 28761239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
